Gemcitabine-cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma: effectiveness outcomes and characterization of the tumor microenvironment

Hepatology International 2026

View at publisher

Authors: Jiawei Xu, Yifan Ji, Min Feng, Zhiheng Zhang, Decai Yu

DOI: 10.1007/s12072-026-11070-y

Cited by: 3

References: 34

Fields of Study & Subjects

Cholangiocarcinoma and Gallbladder Cancer Studies Gallbladder and Bile Duct Disorders Gastric Cancer Management and Outcomes

References 34